國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Contemporary pharmacotherapy of over...

Cox, Lindsey.

Contemporary pharmacotherapy of overactive bladder

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Contemporary pharmacotherapy of overactive bladderedited by Lindsey Cox, Eric S. Rovner.
其他作者:	Cox, Lindsey.
出版者:	Cham :Springer International Publishing :2019.
面頁冊數:	xv, 321 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
標題:	BladderDiseases
電子資源:	https://doi.org/10.1007/978-3-319-97265-7
ISBN:	9783319972657$q(electronic bk.)

Contemporary pharmacotherapy of overactive bladder
Contemporary pharmacotherapy of overactive bladder[electronic resource] /edited by Lindsey Cox, Eric S. Rovner. - Cham :Springer International Publishing :2019. - xv, 321 p. :ill., digital ;24 cm.

Pathophysiology of Overactive Bladder -- Diagnosis of Overactive Bladder. The Placebo Effect in Overactive Bladder Syndrome -- Outcome Measures and Patient Expectations for Overactive Bladder -- National and International Guidelines in Overactive Bladder -- β3-Agonists for Overactive Bladder -- Combination Pharmacotherapy for Overactive Bladder -- Behavioral Therapy in Combination with Pharmacotherapy -- Pharmacotherapy for Nocturia -- Intravesical Chemodenervation and Toxins -- Other Treatment for Overactive Bladder, Including Intravesical -- Future Considerations in Overactive Bladder Pharmacotherapy -- Considerations in Pediatric Overactive Bladder -- Considerations in Male Overactive Bladder -- Considerations in the Medically Complex and Frail Elderly -- Individualizing Drug Therapy.

This text provides a comprehensive, state-of-the art review of pharmacotherapy for the overactive bladder, and serve as a valuable resource forclinicians, surgeons, and researchers with an interest in OAB. The early chapters will describe the pathophysiology of OAB, algorithm, and provide the readers with a practical guide for evaluating the OAB patient. The next section describes the unique challenges involved in the study of OAB and helps the reader navigate the complexities of the literature on the topic. All chapters are written by experts in their fields and include the most up-to-date scientific and clinical information. The text includes a review of the clinical guidelines for OAB, and a detailed description of the individual therapies, including antimuscarinics, Beta-3 agonists, (insert comma) and chemodenervation. Extensive tabulation of contemporary literature makes this a matchless resource that provides a detailed account of the current evidence for the use of each of these therapies. The text concludes with chapters on unique populations with OAB, and future directions in the research field. Contemporary Pharmacotherapy of Overactive Bladder unites a unique set of thought leaders in the field of voiding dysfunction to create a comprehensive resource that will be useful for a variety of clinicians who treat OAB, including urologists, urogynecologists, general gynecologists, family practitioners, and geriatricians.

ISBN: 9783319972657$q(electronic bk.)

Standard No.: 10.1007/978-3-319-97265-7doiSubjects--Topical Terms:

752921
Bladder
--Diseases

LC Class. No.: RC919 / .C668 2019

Dewey Class. No.: 616.62

Contemporary pharmacotherapy of overactive bladder
LDR:03213nmm a2200325 a 4500 001 552193
003 DE-He213
005 20190522153407.0
006 m d
007 cr nn 008maaau
008 191105s2019 gw s 0 eng d
020 $a 9783319972657$q(electronic bk.)
020 $a 9783319972640$q(paper)
024 7 $a 10.1007/978-3-319-97265-7 $2 doi
035 $a 978-3-319-97265-7
040 $a GP $c GP
041 0 $a eng
050 4 $a RC919 $b .C668 2019
072 7 $a MJS $2 bicssc
072 7 $a MED088000 $2 bisacsh
072 7 $a MJS $2 thema
082 0 4 $a 616.62 $2 23
090 $a RC919 $b .C761 2019
245 0 0 $a Contemporary pharmacotherapy of overactive bladder $h [electronic resource] / $c edited by Lindsey Cox, Eric S. Rovner.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2019.
300 $a xv, 321 p. : $b ill., digital ; $c 24 cm.
505 0 $a Pathophysiology of Overactive Bladder -- Diagnosis of Overactive Bladder. The Placebo Effect in Overactive Bladder Syndrome -- Outcome Measures and Patient Expectations for Overactive Bladder -- National and International Guidelines in Overactive Bladder -- β3-Agonists for Overactive Bladder -- Combination Pharmacotherapy for Overactive Bladder -- Behavioral Therapy in Combination with Pharmacotherapy -- Pharmacotherapy for Nocturia -- Intravesical Chemodenervation and Toxins -- Other Treatment for Overactive Bladder, Including Intravesical -- Future Considerations in Overactive Bladder Pharmacotherapy -- Considerations in Pediatric Overactive Bladder -- Considerations in Male Overactive Bladder -- Considerations in the Medically Complex and Frail Elderly -- Individualizing Drug Therapy.
520 $a This text provides a comprehensive, state-of-the art review of pharmacotherapy for the overactive bladder, and serve as a valuable resource forclinicians, surgeons, and researchers with an interest in OAB. The early chapters will describe the pathophysiology of OAB, algorithm, and provide the readers with a practical guide for evaluating the OAB patient. The next section describes the unique challenges involved in the study of OAB and helps the reader navigate the complexities of the literature on the topic. All chapters are written by experts in their fields and include the most up-to-date scientific and clinical information. The text includes a review of the clinical guidelines for OAB, and a detailed description of the individual therapies, including antimuscarinics, Beta-3 agonists, (insert comma) and chemodenervation. Extensive tabulation of contemporary literature makes this a matchless resource that provides a detailed account of the current evidence for the use of each of these therapies. The text concludes with chapters on unique populations with OAB, and future directions in the research field. Contemporary Pharmacotherapy of Overactive Bladder unites a unique set of thought leaders in the field of voiding dysfunction to create a comprehensive resource that will be useful for a variety of clinicians who treat OAB, including urologists, urogynecologists, general gynecologists, family practitioners, and geriatricians.
650 0 $a Bladder $x Diseases $x Treatment. $3 752921
650 0 $a Chemotherapy. $3 218143
650 1 4 $a Urology. $3 318461
650 2 4 $a Gynecology. $3 230246
700 1 $a Cox, Lindsey. $3 832720
700 1 $a Rovner, Eric S. $3 713123
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
856 4 0 $u https://doi.org/10.1007/978-3-319-97265-7
950 $a Medicine (Springer-11650)